CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Director bought 25,016 shares at $3.94 ($98,473)
- 4 Open-market buy Director bought 8,000 shares at an average $3.98 ($31,832)
- 4 Open-market buy Director bought 54,640 shares at an average $3.79 ($207,219)
- 4 Open-market buy Director bought 153,234 shares at an average $3.79 ($580,158)
- 4 Open-market buy Director bought 96,457 shares at an average $3.84 ($370,503)
- 4 Open-market buy SVP, Chief Medical Officer bought 2,500 shares at an average $4.01 ($10,022)
- 4 Open-market buy Director bought 100 shares at $3.85 ($385)
- 4 Open-market buy Director bought 15,764 shares at an average $3.75 ($59,189)
- 4 Open-market buy Director bought 3,303 shares at $3.79 ($12,510)
- 4 Open-market buy Director bought 128,142 shares at an average $3.73 ($477,576)
- 4 Grant or award Director acquired 1,964 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 7,858 shares (grant or award)
- 4 Grant or award Director acquired 7,858 shares (grant or award)
- 4 Open-market sale Sr. VP, Drug Development sold 20,000 shares at an average $5.80 ($116,000)
- 4 Open-market buy Director bought 50,000 shares at $4.89 ($244,500)
- 4 Open-market buy Director bought 100,000 shares at $4.89 ($489,000)
- 4 Open-market buy Director bought 1,431,493 shares at $4.89 ($7,000,001)
- 4 Open-market buy President and CEO bought 5,000 shares at $4.45 ($22,250)
Page 22 of 29 · 564 filings